Skip to main content
    T

    Theriva Biologics Inc. (TOVX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE MKT

    $0.14
    -0.00 (-2.36%)

    Market Cap: $6.61M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Theriva Biologics Inc. (TOVX) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Theriva Biologics (TOVX) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Theriva Biologics reported EPS of -$0.03. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    49%(19/39)
    Avg Surprise
    -36.03%

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.06
    Range-$0.06 - -$0.06
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.05
    Range-$0.05 - -$0.05
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.05
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Next Report

    TOVX has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 39 quarters below that had an estimate, TOVX beat 19, missed 14 and matched 6. The widest gap in the table came in the quarter ended Dec 31, 2018, when EPS landed 582.05% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.03-$0.06-$0.06 - -$0.06N/AN/AN/A10 up, 1 downNov 12, 2026
    Jun 30, 2026-$0.07-$0.05-$0.05 - -$0.05-40.00%MissN/A11 up, 0 downAug 11, 2026
    Mar 31, 2026-$0.05-$0.05-$0.05 - -$0.050.00%In lineN/A11 up, 0 downMay 5, 2026
    Dec 31, 2025-$0.10-$0.37-$0.37 - -$0.37+73.46%BeatN/A11 up, 0 downMar 12, 2026
    Sep 30, 2025-$0.45-$0.38-$0.38 - -$0.38-18.42%MissN/A11 up, 0 downNov 12, 2025
    Jun 30, 2025-$1.93-$0.47-$0.47 - -$0.47-310.64%MissN/A10 up, 0 downAug 11, 2025
    Mar 31, 2025-$1.55-$1.56-$1.56 - -$1.56+0.64%BeatN/A10 up, 0 downMay 14, 2025
    Dec 31, 2024-$11.49-$7.22N/A-59.14%MissN/AN/A0 up, 0 downMar 6, 2025
    Sep 30, 2024-$6.81-$5.25-$7.25 - -$5.25-29.71%MissN/A20 up, 0 downNov 12, 2024
    Jun 30, 2024-$10.75-$4.75N/A-126.32%MissN/AN/A0 up, 0 downAug 13, 2024
    Mar 31, 2024-$7.50-$8.50-$8.50 - -$8.50+11.76%BeatN/A10 up, 0 downMay 7, 2024
    Dec 31, 2023-$0.34-$0.41-$0.49 - -$0.33+17.07%BeatN/A20 up, 0 downMar 25, 2024
    Sep 30, 2023-$4.75-$8.50-$10.25 - -$8.50+44.12%BeatN/A20 up, 0 downNov 13, 2023
    Jun 30, 2023-$8.50-$8.50-$9.50 - -$8.500.00%In lineN/A20 up, 0 downAug 8, 2023
    Mar 31, 2023-$7.50-$8.00-$8.00 - -$8.00+6.25%BeatN/A10 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.33-$0.33N/A0.00%In lineN/AN/A0 up, 0 downMar 30, 2023
    Sep 30, 2022-$8.25-$11.25-$11.25 - -$8.50+26.67%BeatN/A20 up, 0 downNov 10, 2022
    Jun 30, 2022-$7.75-$7.50N/A-3.33%MissN/AN/AN/AAug 11, 2022
    Mar 31, 2022-$0.30-$0.30N/A0.00%In lineN/AN/AN/AMay 16, 2022
    Dec 31, 2021-$10.00-$5.00N/A-100.00%MissN/AN/AN/AMar 16, 2022
    Sep 30, 2021-$5.00-$5.00N/A0.00%In lineN/AN/AN/ANov 3, 2021
    Jun 30, 2021-$5.00-$5.00N/A0.00%In lineN/AN/AN/AAug 5, 2021
    Mar 31, 2021-$32.50-$5.00N/A-550.00%MissN/AN/AN/AMay 5, 2021
    Dec 31, 2020-$1.40-$0.80N/A-75.00%MissN/AN/AN/AMar 4, 2021
    Sep 30, 2020-$35.00-$40.00N/A+12.50%BeatN/AN/AN/ANov 10, 2020
    Jun 30, 2020-$45.00-$35.00N/A-28.57%MissN/AN/AN/AAug 6, 2020
    Mar 31, 2020-$1.70-$2.70N/A+37.04%BeatN/AN/AN/AMay 5, 2020
    Dec 31, 2019-$47.50-$57.50N/A+17.39%BeatN/AN/AN/AFeb 20, 2020
    Sep 30, 2019-$77.50-$57.50N/A-34.78%MissN/AN/AN/ANov 4, 2019
    Jun 30, 2019-$2.20-$2.30N/A+4.35%BeatN/AN/AN/AAug 8, 2019
    Mar 31, 2019-$2.20-$2.30N/A+4.35%BeatN/AN/AN/AMay 8, 2019
    Dec 31, 2018-$332.50-$48.75N/A-582.05%Miss-4850.0%N/AN/AFeb 27, 2019
    Sep 30, 2018-$232.50-$525.00N/A+55.71%BeatN/AN/AN/ANov 8, 2018
    Jun 30, 2018-$262.50-$350.00N/A+25.00%BeatN/AN/AN/AAug 8, 2018
    Mar 31, 2018-$175.00-$437.50N/A+60.00%BeatN/AN/AN/AMay 8, 2018
    Dec 31, 2017$7.00-$16.33N/A+142.87%BeatN/AN/AN/AFeb 22, 2018
    Sep 30, 2017-$1,225.00-$437.50N/A-180.00%MissN/AN/AN/ANov 1, 2017
    Jun 30, 2017-$262.50-$495.83N/A+47.06%BeatN/AN/AN/AAug 3, 2017
    Mar 31, 2017-$175.00-$641.67N/A+72.73%BeatN/AN/AN/AMay 4, 2017
    Dec 31, 2016-$7.00-$26.60N/A+73.68%BeatN/AN/AN/AMar 2, 2017
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.03, after -$36.55 the year before. It was -$2,750.38 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.03N/A
    Dec 31, 2024-$36.55N/A
    Dec 31, 2023-$21.09N/A
    Dec 31, 2022-$16.63N/A
    Dec 31, 2021-$52.50N/A
    Dec 31, 2020-$83.10N/A
    Dec 31, 2019-$129.40N/A
    Dec 31, 2018-$1,002.50N/A
    Dec 31, 2017-$1,655.50N/A
    Dec 31, 2016-$2,750.38N/A

    Frequently Asked Questions About TOVX

    When is Theriva Biologics's next earnings date?

    Theriva Biologics's next earnings report is expected for Mar 10, 2027.

    What EPS do analysts expect from TOVX next quarter?

    The consensus EPS estimate for Theriva Biologics for the quarter ending Dec 31, 2026 is -$0.06 from 3 analysts, with estimates from -$0.06 to -$0.06.

    How often does TOVX beat earnings estimates?

    Theriva Biologics beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -47.98%.